These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 29693337)
1. Impact of Mesenchymal Stem Cells and Vitamin D on Transforming Growth Factor Beta Signaling Pathway in Hepatocellular Carcinoma in Rats. Saad El-Din S; Fouad H; Rashed LA; Mahfouz S; Hussein RE Asian Pac J Cancer Prev; 2018 Apr; 19(4):905-912. PubMed ID: 29693337 [TBL] [Abstract][Full Text] [Related]
2. Altered Cell to Cell Communication, Autophagy and Mitochondrial Dysfunction in a Model of Hepatocellular Carcinoma: Potential Protective Effects of Curcumin and Stem Cell Therapy. Tork OM; Khaleel EF; Abdelmaqsoud OM Asian Pac J Cancer Prev; 2015; 16(18):8271-9. PubMed ID: 26745072 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of mesenchymal stem cells in suppression of hepatocarcinorigenesis in rats: possible role of Wnt signaling. Abdel aziz MT; El Asmar MF; Atta HM; Mahfouz S; Fouad HH; Roshdy NK; Rashed LA; Sabry D; Hassouna AA; Taha FM J Exp Clin Cancer Res; 2011 May; 30(1):49. PubMed ID: 21545718 [TBL] [Abstract][Full Text] [Related]
4. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail. Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833 [TBL] [Abstract][Full Text] [Related]
5. A novel chemoprotective effect of tiopronin against diethylnitrosamine-induced hepatocellular carcinoma in rats: Role of ASK1/P38 MAPK-P53 signalling cascade. Mo'men YS; Hussein RM; Kandeil MA Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):322-332. PubMed ID: 31663622 [TBL] [Abstract][Full Text] [Related]
6. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model. Helmy SA; El-Mesery M; El-Karef A; Eissa LA; El Gayar AM Life Sci; 2019 Sep; 233():116673. PubMed ID: 31336121 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro. Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826 [TBL] [Abstract][Full Text] [Related]
8. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Ding ZY; Jin GN; Wang W; Chen WX; Wu YH; Ai X; Chen L; Zhang WG; Liang HF; Laurence A; Zhang MZ; Datta PK; Zhang B; Chen XP Hepatology; 2014 Nov; 60(5):1620-36. PubMed ID: 24954480 [TBL] [Abstract][Full Text] [Related]
9. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma. Sun H; Peng Z; Tang H; Xie D; Jia Z; Zhong L; Zhao S; Ma Z; Gao Y; Zeng L; Luo R; Xie K Oncogene; 2017 May; 36(21):2957-2968. PubMed ID: 28192402 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects. Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983 [TBL] [Abstract][Full Text] [Related]
11. Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis. Jang YO; Cho MY; Yun CO; Baik SK; Park KS; Cha SK; Chang SJ; Kim MY; Lim YL; Kwon SO Stem Cells Transl Med; 2016 Sep; 5(9):1247-56. PubMed ID: 27365486 [TBL] [Abstract][Full Text] [Related]
12. Thiamin Regresses the Anticancer Efficacy of Methotrexate in the Amelioration of Diethyl Nitrosamine-Induced Hepatocellular Carcinoma in Wistar Strain Rats. Saleem S; Kazmi I; Ahmad A; Abuzinadah MF; Samkari A; Alkrathy HM; Khan R Nutr Cancer; 2020; 72(1):170-181. PubMed ID: 31088230 [No Abstract] [Full Text] [Related]
13. [Study of mesenchymal stem cells transfected with oncogenes differentiate into hepatocellular carcinoma of rats]. Zhang GQ; Fang CH; Gao P; Yan Z; Zheng Q; Chen GH Zhonghua Wai Ke Za Zhi; 2007 May; 45(9):605-8. PubMed ID: 17688794 [TBL] [Abstract][Full Text] [Related]
14. The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis. Motawi TM; Atta HM; Sadik NA; Azzam M Cell Biochem Biophys; 2014 Jan; 68(1):111-25. PubMed ID: 23807535 [TBL] [Abstract][Full Text] [Related]
15. Potential Molecular Targets of Statins in the Prevention of Hepatocarcinogenesis. Ridruejo E; Romero-Caími G; Obregón MJ; Kleiman de Pisarev D; Alvarez L Ann Hepatol; 2018; 17(3):490-500. PubMed ID: 29735800 [TBL] [Abstract][Full Text] [Related]
16. Effects of mesenchymal stem cells versus curcumin on sonic hedgehog signaling in experimental model of Hepatocellular Carcinoma. Abdel-Tawab MS; Fouad H; Sedeak AY; Doudar NA; Rateb EE; Faruk E; Reyad HR Mol Biol Rep; 2024 Jun; 51(1):740. PubMed ID: 38874802 [TBL] [Abstract][Full Text] [Related]
17. Curcumin ameliorate DENA-induced HCC via modulating TGF-β, AKT, and caspase-3 expression in experimental rat model. Abouzied MM; Eltahir HM; Abdel Aziz MA; Ahmed NS; Abd El-Ghany AA; Abd El-Aziz EA; Abd El-Aziz HO Tumour Biol; 2015 Mar; 36(3):1763-71. PubMed ID: 25519685 [TBL] [Abstract][Full Text] [Related]
18. Liver specific overexpression of platelet-derived growth factor-B accelerates liver cancer development in chemically induced liver carcinogenesis. Maass T; Thieringer FR; Mann A; Longerich T; Schirmacher P; Strand D; Hansen T; Galle PR; Teufel A; Kanzler S Int J Cancer; 2011 Mar; 128(6):1259-68. PubMed ID: 20506153 [TBL] [Abstract][Full Text] [Related]
19. Dual regulating of mitochondrial fusion and Timp-3 by leflunomide and diallyl disulfide combination suppresses diethylnitrosamine-induced hepatocellular tumorigenesis in rats. Abdel-Hamid NM; Abass SA; Eldomany RA; Abdel-Kareem MA; Zakaria S Life Sci; 2022 Apr; 294():120369. PubMed ID: 35120919 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1. Yang L; Inokuchi S; Roh YS; Song J; Loomba R; Park EJ; Seki E Gastroenterology; 2013 May; 144(5):1042-1054.e4. PubMed ID: 23391818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]